Beam Therapeutics (BEAM) Cash & Equivalents (2019 - 2026)
Beam Therapeutics' Cash & Equivalents was $219.83 million in Q2 2026, down 22.1% from $282.13 million a year earlier and down 23.7% from the prior quarter.
Powered by 
Analysis
Beam Therapeutics (BEAM) Cash & Equivalents (2019 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Beam Therapeutics came in at $294.94 million, up 4.6% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 12.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $281.97 million in FY2024 (-35.3%), $435.9 million in FY2023 (+87.3%), $232.77 million in FY2022 (-58.4%) and $559.99 million in FY2021 (+245.3%).
- The Q2 2026 figure marks the lowest quarterly Cash & Equivalents since Q3 2023.
- Compared with a year earlier, Cash & Equivalents was higher in four of the last eight quarters, with growth averaging 4.3%.
- The best year-over-year quarter for Cash & Equivalents over five years was Q3 2021 (growth of 343.8%); the worst was Q3 2022 (a decline of 74.4%).
- Per Business Quant data, BEAM's Cash & Equivalents in the three quarters before Q2 2026 was $288.29 million (Q1 2026), $294.94 million (Q4 2025) and $267.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 20.42 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 6.57 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.85 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 7.62 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 13.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.18 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 976.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 6.14 Bn |
| 10 | Beam Therapeutics | 2.52 Bn | 2.52 Bn | - | 219.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 219.83 Mn |
| Mar 31, 2026 | 288.29 Mn |
| Dec 31, 2025 | 294.94 Mn |
| Sep 30, 2025 | 267.96 Mn |
| Jun 30, 2025 | 282.13 Mn |
| Mar 31, 2025 | 527.91 Mn |
| Dec 31, 2024 | 281.97 Mn |
| Sep 30, 2024 | 230.20 Mn |
| Jun 30, 2024 | 292.76 Mn |
| Mar 31, 2024 | 287.85 Mn |
| Dec 31, 2023 | 435.90 Mn |
| Sep 30, 2023 | 169.05 Mn |
| Jun 30, 2023 | 225.54 Mn |
| Mar 31, 2023 | 249.77 Mn |
| Dec 31, 2022 | 232.77 Mn |
| Sep 30, 2022 | 156.51 Mn |
| Jun 30, 2022 | 265.62 Mn |
| Mar 31, 2022 | 296.82 Mn |
| Dec 31, 2021 | 559.99 Mn |
| Sep 30, 2021 | 612.02 Mn |
API Access
Beam Therapeutics Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BEAM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BEAM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BEAM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();